These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31150976)

  • 1. Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2019 Aug; 129():343-353. PubMed ID: 31150976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using 2003-2014 U.S. NHANES data to determine the associations between per- and polyfluoroalkyl substances and cholesterol: Trend and implications.
    Dong Z; Wang H; Yu YY; Li YB; Naidu R; Liu Y
    Ecotoxicol Environ Saf; 2019 May; 173():461-468. PubMed ID: 30798190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Fleisch AF; Calafat AM; Sanchez-Guerra M; Osorio-Yáñez C; Webster TF; Horton ES; Oken E
    Environ Int; 2020 Apr; 137():105217. PubMed ID: 32086073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial.
    Cardenas A; Gold DR; Hauser R; Kleinman KP; Hivert MF; Calafat AM; Ye X; Webster TF; Horton ES; Oken E
    Environ Health Perspect; 2017 Oct; 125(10):107001. PubMed ID: 28974480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
    Kang H; Kim SH
    Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Perfluoroalkyl Substances and Lipids in Cord Blood.
    Spratlen MJ; Perera FP; Lederman SA; Robinson M; Kannan K; Herbstman J; Trasande L
    J Clin Endocrinol Metab; 2020 Jan; 105(1):43-54. PubMed ID: 31536623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated measurements of per- and polyfluoroalkyl substances (PFASs) from 1979 to 2007 in males from Northern Norway: assessing time trends, compound correlations and relations to age/birth cohort.
    Nøst TH; Vestergren R; Berg V; Nieboer E; Odland JØ; Sandanger TM
    Environ Int; 2014 Jun; 67():43-53. PubMed ID: 24657493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Per- and polyfluoroalkyl substances and kidney function: Follow-up results from the Diabetes Prevention Program trial.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2021 Mar; 148():106375. PubMed ID: 33482440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study.
    Liu G; Zhang B; Hu Y; Rood J; Liang L; Qi L; Bray GA; DeJonge L; Coull B; Grandjean P; Furtado JD; Sun Q
    Environ Health; 2020 Jan; 19(1):5. PubMed ID: 31931806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends of concentrations of per- and polyfluoroalkyl substances among adults with overweight and obesity in the United States: Results from the Diabetes Prevention Program and NHANES.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2021 Dec; 157():106789. PubMed ID: 34333293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the impact of polyfluoroalkyl substance exposure on erythrocyte profiles and its related nutrients: Insights from a prospective study on young Taiwanese.
    Lin CY; Lee HL; Wang C; Sung FC; Su TC
    Environ Pollut; 2024 Oct; 359():124576. PubMed ID: 39032552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis.
    Alderete TL; Jin R; Walker DI; Valvi D; Chen Z; Jones DP; Peng C; Gilliland FD; Berhane K; Conti DV; Goran MI; Chatzi L
    Environ Int; 2019 May; 126():445-453. PubMed ID: 30844580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-cohort study of per- and polyfluoroalkyl substance concentrations and incident prostate cancer in the cancer prevention Study-II LifeLink cohort study.
    Troeschel AN; Teras LR; Hodge JM; Rodriguez J; Wang Y; Daniel J; Diver WR; Winquist A
    Environ Res; 2024 Oct; 259():119560. PubMed ID: 38971361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease.
    Cardenas A; Hivert MF; Gold DR; Hauser R; Kleinman KP; Lin PD; Fleisch AF; Calafat AM; Ye X; Webster TF; Horton ES; Oken E
    Diabetes Care; 2019 Sep; 42(9):1824-1832. PubMed ID: 31296647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isomers of per- and polyfluoroalkyl substances and uric acid in adults: Isomers of C8 Health Project in China.
    Zeng XW; Lodge CJ; Dharmage SC; Bloom MS; Yu Y; Yang M; Chu C; Li QQ; Hu LW; Liu KK; Yang BY; Dong GH
    Environ Int; 2019 Dec; 133(Pt A):105160. PubMed ID: 31518937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between perfluoroalkyl substances and lipid profile in exposed pregnant women in the Veneto region, Italy.
    Dalla Zuanna T; Savitz DA; Barbieri G; Pitter G; Zare Jeddi M; Daprà F; Fabricio ASC; Russo F; Fletcher T; Canova C
    Ecotoxicol Environ Saf; 2021 Feb; 209():111805. PubMed ID: 33360787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels.
    Mora AM; Fleisch AF; Rifas-Shiman SL; Woo Baidal JA; Pardo L; Webster TF; Calafat AM; Ye X; Oken E; Sagiv SK
    Environ Int; 2018 Feb; 111():1-13. PubMed ID: 29156323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.